share_log

Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics

Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics

預測未來:13位分析師對nurix therapeutics的預測
Benzinga ·  07/31 23:01
Throughout the last three months, 13 analysts have evaluated Nurix Therapeutics (NASDAQ:NRIX), offering a diverse set of opinions from bullish to bearish.
過去三個月,13位分析師對 Nurix Therapeutics(納斯達克股票代碼:NRIX)進行了評估,提供了從看好到看淡的不同觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估,下表展示了過去30天內不斷變化的情緒,並將其與之前的幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $29.54, a high estimate of $36.00, and a low estimate of $20.00. This current average reflects an increase of 6.64% from the previous average price target of $27.70.
分析師們12個月的目標股價的見解被揭示,顯示出一個平均目標爲29.54美元、一個最高估值爲36.00美元和一個最低估值爲20.00美元。當前的平均目標股價反映了6.64%的上漲,相對於之前的平均目標股價27.70美元。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀:深入分析
The standing of Nurix Therapeutics among financial experts becomes clear with a thorough...
通過對最近分析師行爲的徹底...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論